Emerging evidence pointed out that defective activation of TFEB probably underlies aberrant lysosomal function failing to degrade aggregated toxic proteins in prevalent neurodegenerative diseases (Decressac et al., 2013; Tsunemi et al., 2012; Xiao et al., 2014). The gene discussed is TFEB; the disease is neurodegenerative disease.